Fosun International receives ESG Excellence Award from Hong Kong Economic Journal

Fosun International has been honored with the “Outstanding ESG Sustainable Enterprise Award” at the 2026 ESG Sustainable Development Awards ceremony hosted by the Hong Kong Economic Journal. The award recognizes the company’s performance in environmental, social, and governance sectors.

Fosun International has achieved an MSCI ESG rating of AAA and has been included in the S&P Global Sustainability Yearbook 2026. The company has committed to reaching peak carbon emissions by 2028 and achieving carbon neutrality by 2050. In terms of social impact, Fosun Pharma has supplied over 460 million doses of artemether combination therapy to the global market, treating over 92 million malaria patients.

Additionally, the Fosun Foundation continues to operate programs in rural revitalization, healthcare, and youth entrepreneurship, including the Protecting global youth innovation project.